NCT03497000View on ClinicalTrials.gov

Effects of OCTA-guided PDT in Acute CSC

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

March 27, 2018

Conditions
Central Serous ChorioretinopathyTomography, Optical Coherence
Interventions
PROCEDURE

OCTA-guided Photodynamic therapy

Half-dose photodynamic therapy using verteporfin under the guidance of OCTA

PROCEDURE

ICGA-guided Photodynamic therapy

Half-dose photodynamic therapy using verteporfin under the guidance of ICGA

Trial Locations (1)

100044

People's Hospital of Peking University, Beijing

All Listed Sponsors
collaborator

National Natural Science Foundation of China

OTHER_GOV

lead

Peking University People's Hospital

OTHER

NCT03497000 - Effects of OCTA-guided PDT in Acute CSC | Biotech Hunter | Biotech Hunter